Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 1984;17(3):180-9.
doi: 10.1007/BF00205483.

Activity of antibodies recovered from immune complexes of ovarian cancer patients

Activity of antibodies recovered from immune complexes of ovarian cancer patients

P M Lutz et al. Cancer Immunol Immunother. 1984.

Abstract

Ascites fluids from ovarian cancer patients contain immune complexes (IC). Attempts were made to characterize those antigens to which the patient is reacting using antibody recovered from these complexes. Polyethylene glycol (PEG) precipitation and protein A Sepharose 4B affinity chromatography were used to isolate IC. Dissociation of the IC was achieved by G-150 gel filtration in 0.1 M acetic acid, 0.15 M NaCl. Activity of antibody preparations was measured using a binding assay with 125I-labeled staphylococcal protein A. Confluent monolayers of various cell lines (including human ovarian and cervical carcinoma lines, human lymphoblastoid cell lines, human and chick embryo fibroblasts) were used. Six of nine antibody preparations isolated from ovarian cancer patient IC contained at least some reactivity against all cell types. Specificity was further defined using cell adsorption assays and polyacrylamide gel electrophoresis. These results indicate what appears to be autoreactivity directed against a normal component(s) of many cells. No evidence for an ovarian cancer-restricted response was shown. Immunoprecipitation analyses showed several polypeptide bands on autoradiograms (49K, 46K, 33K, 25K), which deviated distinctly from the pattern obtained for whole cell extracts.

PubMed Disclaimer

Similar articles

Cited by

References

    1. Barber HRK. Ovarian cancer. Part 1. CA. 1979;29:342.
    1. Bhattacharya N, Barlow JJ. Ovarian cystadenocarcinoma associated antigen (OCAA) In: Herberman RB, editor. Compendium of assays for immunodiagnosis of human cancer. New York: Elsevier/North-Holland; 1979. p. 527.
    1. Bhattacharya M, Chatterjee SK, Barlow JJ. Uridine 5′-diphosphate-galactose: glycoprotein galactosyltransferase activity in the ovarian cancer patient. Cancer Res. 1976;36:2096. - PubMed
    1. Brown JP, Klitzman JM, Hellstrom KE. A microassay for antibody binding to tumor cell surface antigens using 125I-labeled protein A from Staphylococcus aureus. J Immunol Methods. 1977;15:57. - PubMed
    1. Clayton LA, Gall SA, Dawson JR, Creasman WT. Immune complexes in ovarian cancer. Gynecol Oncol. 1982;13:203. - PubMed

Publication types

LinkOut - more resources